Since many types of cancer express relatively high levels of P-glycoprotein, a major type of MDR protein (28), we show that, unlike Hsp90 inhibitors such as 17-AAG and its derivatives (29), SST0116CL1 exhibited no MDR dependency in A2780/ADR tumor xenograft model. Here, HSP90AA1 is linked to neoplasm.